Expression of a TMC6-TMC8-CIB1 heterotrimeric complex in lymphocytes is regulated by each of the components

• Published in: The Journal of biological chemistry Vol. 295; no. 47; pp. 16086 - 16099
• Main Authors: Wu, Chuan-Jin, Li, Xing, Sommers, Connie L., Kurima, Kiyoto, Huh, Sunmee, Bugos, Grace, Dong, Lijin, Li, Wenmei, Griffith, Andrew J., Samelson, Lawrence E.
• Format: Journal Article
• Language: English
• Published: United States Elsevier Inc 20.11.2020; American Society for Biochemistry and Molecular Biology
• Subjects: Animals; Calcium-Binding Proteins - genetics; Calcium-Binding Proteins - metabolism; CIB1; epidermodysplasia verruciformis; heteromeric complex; HPV; Humans; Jurkat Cells; keratinocyte; keratinocytes; Keratinocytes - cytology; Keratinocytes - metabolism; lymphocyte; lymphocytes; Membrane Proteins - genetics; Membrane Proteins - metabolism; Mice; Multiprotein Complexes - genetics; Multiprotein Complexes - metabolism; protein complex; protein degradation; Proteolysis; Signal Transduction; T cells; T-Lymphocytes - cytology; T-Lymphocytes - metabolism; TMC6; TMC8; transmembrane channel protein; ubiquitin-dependent protease; Ubiquitination; lymphocytes; transmembrane channel protein; TMC8; ubiquitin-dependent protease; CIB1; TMC6; keratinocytes; T cells; protein complex; HPV; lymphocyte; keratinocyte; epidermodysplasia verruciformis; heteromeric complex; protein degradation
• ISSN: 0021-9258; 1083-351X
• DOI: 10.1074/jbc.RA120.013045

The TMC genes encode a set of homologous transmembrane proteins whose functions are not well understood. Biallelic mutations in either TMC6 or TMC8 are detected in more than half of cases of the pre-malignant skin disease epidermodysplasia verruciformis (EV). It is controversial whether EV induced by mutations in TMC6 or TMC8 originates from keratinocyte or lymphocyte defects. Quantification of TMC6 and TMC8 RNA levels in various organs revealed that lymphoid tissues have the highest levels of expression of both genes, and custom antibodies confirmed protein expression in mouse lymphocytes. To study the function of these proteins we generated mice with targeted deletion mutant alleles of Tmc6 or Tmc8. Either TMC6 or TMC8 deficiency induced a reduction in apparent molecular weight and/or amount of the other TMC molecule. Co-immunoprecipitation experiments indicated that TMC6 and TMC8 formed a protein complex in mouse and human T cells. MS and biochemical analysis demonstrated that TMC6 and TMC8 additionally interacted with the CIB1 protein to form TMC6-TMC8-CIB1 trimers. We demonstrated that TMC6 and TMC8 regulated CIB1 levels by protecting CIB1 from ubiquitination and proteasomal degradation. Reciprocally, CIB1 was needed for stabilizing TMC6 and TMC8 levels. These results suggest why inactivating mutations in any of the three human genes leads to similar clinical presentations. We also demonstrated that TMC6 and TMC8 levels are drastically lower and the proteins are less active in regulating CIB1 in keratinocytes than in T cells. Our study suggests that defects in lymphocytes may contribute to the etiology and pathogenesis of EV.